Search jobs 01-Feb-2021 Vivo Capital and an Investor Syndicate Completes Sale of Surgical Specialties Corporation to GTCR-backed Corza Health
PALO ALTO, Calif. (BUSINESS WIRE) Vivo Capital, a global healthcare investment firm, announced today that it has closed the sale of Surgical Specialties Corporation (“SSC”) to Corza Health, a portfolio company of GTCR, a global private equity firm.
Vivo Capital and an investor syndicate including certain Vivo limited partner co-investors acquired SSC, a global manufacturer and leader in the medical device consumables segment, in 2017. Since then, SSC has acquired three companies, divested one product line to Angiodynamics, and built two factories in the US and China while reinvigorating the company’s iconic brands, including Quill™ and Sharpoint™.